Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults

Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults

Artemisinin-based combination therapies (ACTs) have contributed substantially to the global decline in Plasmodium falciparum morbidity and mortality, but resistance to artemisinins and their partner drugs is increasing in Southeast Asia, threatening malaria control. New antimalarial compounds will n...

書誌詳細
主要な著者:	Hanboonkunupakarn, B, Van Der Pluijm, R, Hoglund, R, Pukrittayakamee, S, Winterberg, M, Mukaka, M, Waithira, N, Chotivanich, K, Singhasivanon, P, White, N, Dondorp, A, Tarning, J, Jittamala, P
フォーマット:	Journal article
言語:	English
出版事項:	American Society for Microbiology 2019

類似資料

Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects
著者:: Kobylinski, KC, 等
出版事項: (2019)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
著者:: Chotsiri, P, 等
出版事項: (2017)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
著者:: Hanboonkunupakarn, B, 等
出版事項: (2014)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
著者:: Von Seidlein, L, 等
出版事項: (2019)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
著者:: Tarning, J, 等
出版事項: (2024)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
著者:: Lorenz von Seidlein, 等
出版事項: (2020-01-01)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
著者:: Joel Tarning, 等
出版事項: (2024-10-01)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
著者:: Rijken, M, 等
出版事項: (2011)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
著者:: Valecha, N, 等
出版事項: (2010)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
著者:: Valecha, N, 等
出版事項: (2010)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
著者:: Neena Valecha, 等
出版事項: (2010-01-01)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
著者:: Tarning, J, 等
出版事項: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
著者:: Tarning, J, 等
出版事項: (2012)

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
著者:: van Der Pluijm, R, 等
出版事項: (2019)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
著者:: Neena Valecha, 等
出版事項: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
著者:: Neena Valecha, 等
出版事項: (2010-01-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
著者:: Awab, G, 等
出版事項: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
著者:: Tarning, J, 等
出版事項: (2008)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
著者:: Tarning, J, 等
出版事項: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
著者:: Smithuis, F, 等
出版事項: (2006)

Pharmacokinetics of piperaquine and safety profile of dihydroartemisinin-piperaquine co-administered with antiretroviral therapy in malaria-uninfected HIV-positive Malawian adults
著者:: Banda, C, 等
出版事項: (2018)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
出版事項: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
出版事項: (2010-01-01)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated <it>Plasmodium falciparum</it> malaria in India
著者:: Gargano Nicola, 等
出版事項: (2012-07-01)

Efficacy and safety of dihydroartemisinin-piperaquine.
著者:: Myint, H, 等
出版事項: (2007)

A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
著者:: Saito, M, 等
出版事項: (2021)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
著者:: Zongo, I, 等
出版事項: (2014)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
著者:: Permala, J, 等
出版事項: (2017)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
著者:: Woodrow Charles J, 等
出版事項: (2010-04-01)

A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border
著者:: Makoto Saito, 等
出版事項: (2021-06-01)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
著者:: Phuc, B, 等
出版事項: (2017)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
著者:: Mytton, O, 等
出版事項: (2007)

Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand
著者:: Khine Nwe Win, 等
出版事項: (2022-11-01)

Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
著者:: Jittamala, P, 等
出版事項: (2015)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
著者:: Chotsiri, P, 等
出版事項: (2019)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
著者:: Byakika-Kibwika, P, 等
出版事項: (2019)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
著者:: Lwin, K, 等
出版事項: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
著者:: Lwin, K, 等
出版事項: (2012)

An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
著者:: Mayxay, M, 等
出版事項: (2006)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
著者:: Jittamala, P, 等
出版事項: (2014)